Integrity of Randomized Clinical Trials
How to prevent research misconduct and ensure transparency
Seiten
2024
CRC Press (Verlag)
978-1-032-60122-9 (ISBN)
CRC Press (Verlag)
978-1-032-60122-9 (ISBN)
- Noch nicht erschienen (ca. Dezember 2024)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. It is therefore more important than ever that ethics, transparency and professionalism explicitly guide research integrity.
Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at undergraduate nor at postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness and trustworthiness of clinical trials and filling a current void in the market.
Key Features:
The first book on clinical trial integrity.
Provides clear guidance on how to ensure probity in peer review, appraisal of trials and investigation of complaints concerning misconduct in clinical trials.
Trains and supports researchers globally in how to undertake trials with integrity.
Ensures the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met.
The book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, funders and regulators of clinical trials.
Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at undergraduate nor at postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness and trustworthiness of clinical trials and filling a current void in the market.
Key Features:
The first book on clinical trial integrity.
Provides clear guidance on how to ensure probity in peer review, appraisal of trials and investigation of complaints concerning misconduct in clinical trials.
Trains and supports researchers globally in how to undertake trials with integrity.
Ensures the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met.
The book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, funders and regulators of clinical trials.
Khalid S. Khan is Beatriz Galindo Distinguished Investigator at the University of Granada, Spain and has been Sims Black Fellow of the UK Royal College of Obstetricians and Gynaecologists, Spinoza Professor at the University of Amsterdam, the Netherlands, Fellow of the Pakistani College of Physicians and Surgeons, and Fellow of the UK Higher Education Academy.
1. Introduction
2. Randomized clinical trials
3. Integrity of trials
4. Ethics committee approval and participant consent
5. Trial planning
6. Trial oversight
7. Publishing trials responsibly
8. Authorship of trials
9. Evidence syntheses of randomized clinical trials
10. Investigating research misconduct allegations
Suggested reading
Glossary
Index
| Erscheint lt. Verlag | 26.12.2024 |
|---|---|
| Zusatzinfo | 3 Tables, black and white; 15 Line drawings, black and white; 15 Illustrations, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Studium ► Querschnittsbereiche ► Epidemiologie / Med. Biometrie | |
| Naturwissenschaften ► Biologie | |
| Technik | |
| ISBN-10 | 1-032-60122-1 / 1032601221 |
| ISBN-13 | 978-1-032-60122-9 / 9781032601229 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
ein überfälliges Gespräch zu einer Pandemie, die nicht die letzte …
Buch | Hardcover (2024)
Ullstein Buchverlage
CHF 34,95
